Skip to content

GeneLit

Taming the Medical Literature ~ For Genetic Conditions ~ Hand-Curated • Direct to You

  • Home
  • Subscribe to GeneLit
  • Conditions & Syndromes
    • Genetics of Breast & Ovarian Cancer
  • Topics
  • Contact GeneLit
  • Get LitAlerts
  • Terms and Conditions

Home

    • Rucaparib Meets rPFS End Point in BRCA/ATM-Mutated mCRPC.
    • Ryan C.
    • OncLive. 2022 Oct 3.
    • News
    • Free Full Text

    Related:

    Identifier: NCT02975934: A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3). (ClinicalTrials.gov . Accessed 2022 Oct 5.)

  • Posted on October 5, 2022October 5, 2022Author Steve KopczakCategories Male Breast Cancer

    Post navigation

    Previous Previous post: Previous Post
    Next Next post: Next Post
    Proudly powered by WordPress